RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-6.87%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.23B
AUM Growth
+$6.23B
(-6.1%)
Cap. Flow
+$768M
Cap. Flow
% of AUM
12.33%
Top 10 Holdings %
Top 10 Hldgs %
46.21%
Holding
101
New
19
Increased
9
Reduced
3
Closed
9
Top Buys
| 1 |
Janux Therapeutics
JANX
|
$216M |
| 2 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$189M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$113M |
| 4 |
LENZ
LENZ Therapeutics
LENZ
|
$82.9M |
| 5 |
CNTB
Connect Biopharma
CNTB
|
$78.1M |
Top Sells
| 1 |
Novavax
NVAX
|
$93.9M |
| 2 |
Adverum Biotechnologies
ADVM
|
$92.3M |
| 3 |
IGMS
IGM Biosciences
IGMS
|
$75.4M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$52.4M |
| 5 |
TG Therapeutics
TGTX
|
$50.2M |
Sector Composition
| 1 | Healthcare | 97.5% |
| 2 | Financials | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $895M | 14.37% | 6,806,341 +394,113 | +6% | +$51.8M |
|
|
2
Novavax
NVAX
$1.21B
| $543M | 8.72% | 2,559,918 -442,169 | -15% | -$93.9M |
|
|
FMTX
3
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $224M | 3.6% | 9,011,651 | – | – |
|
|
4
Janux Therapeutics
JANX
$1.37B
| $216M | 3.47% | +8,670,644 | New | +$216M |
|
5
Vor Biopharma
VOR
$250M
| $207M | 3.33% | 11,120,973 | – | – |
|
|
JBIO
6
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $189M | 3.03% | +8,263,982 | New | +$189M |
|
7
Nkarta
NKTX
$151M
| $178M | 2.85% | 5,605,129 | – | – |
|
8
MacroGenics
MGNX
$112M
| $160M | 2.56% | 5,943,594 +1,010,000 | +20% | +$27.1M |
|
|
CNTB
9
Connect Biopharma
CNTB
$115M
| $137M | 2.19% | 6,991,003 +3,999,795 | +134% | +$78.1M |
|
|
10
TG Therapeutics
TGTX
$4.65B
| $130M | 2.08% | 3,342,743 -1,293,403 | -28% | -$50.2M |
|
|
IMGN
11
DELISTED
Immunogen Inc
IMGN
| $121M | 1.95% | 18,417,458 | – | – |
|
12
Atea Pharmaceuticals
AVIR
$267M
| $115M | 1.85% | 5,368,451 | – | – |
|
13
iTeos Therapeutics
ITOS
| $113M | 1.82% | 4,417,259 +1 | +0% | +$26 |
|
|
14
Day One Biopharmaceuticals
DAWN
$769M
| $113M | 1.81% | +4,965,588 | New | +$113M |
|
15
Axsome Therapeutics
AXSM
$6.05B
| $112M | 1.79% | 1,655,447 | – | – |
|
16
Phathom Pharmaceuticals
PHAT
$864M
| $105M | 1.69% | 3,115,008 | – | – |
|
17
Instil Bio
TIL
$182M
| $94.1M | 1.51% | 4,870,793 | – | – |
|
18
Rocket Pharmaceuticals
RCKT
$354M
| $93.3M | 1.5% | 2,107,149 | – | – |
|
19
89bio
ETNB
$1.34B
| $92.9M | 1.49% | 4,965,769 +229,555 | +5% | +$4.29M |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $91.3M | 1.47% | 5,283,976 | – | – |
|
21
Vaxcyte
PCVX
$4B
| $87M | 1.4% | 3,865,808 | – | – |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $83.6M | 1.34% | 3,593,052 | – | – |
|
|
LENZ
23
LENZ Therapeutics
LENZ
$1.1B
| $82.9M | 1.33% | +2,698,369 | New | +$82.9M |
|
24
Travere Therapeutics
TVTX
$1.56B
| $81.9M | 1.31% | 5,614,428 | – | – |
|
25
Werewolf Therapeutics
HOWL
$59.9M
| $74.9M | 1.2% | +4,291,881 | New | +$74.9M |
|